We are composed of Sumitomo Pharma (Suzhou) Co., Ltd. and Sumitomo Pharmaceutical (China) Co., Ltd.. Since its entry into the Chinese market in the 1990s,Sumitomo Pharma (Suzhou) Co., Ltd.has been making comprehensive efforts to advance the market for 26 years, considering China as an important global partner. Over the years, Sumitomo Pharma (Suzhou) Co., Ltd.has adhered to the concept of patient-oriented management. Its pharmaceutical products encompass the field of the central nervous system, infection prevention, and cardiovascular diseases.
Presently, we has branch offices in Shanghai, Beijing, and Guangzhou. A plant in Suzhou was set up to ensure drug safety. Sumitomo Pharma (Suzhou) Co., Ltd.always silently takes active actions for China's social welfare. Since the launch of a program to assist poverty-stricken areas in 2009, we has been supporting charities in China for 14 years, supporting nearly 17 projects.
We pay attention to the mental health education and popularization of science for Chinese teenagers and continuously deliver lectures on the popularization of mental health knowledge among college students around the country. Moreover, we care about families suffering from mental illnesses, and support programs such as WABC and CAFF that can help these families establish platforms for communication with society. Meanwhile, Sumitomo Pharma (Suzhou) Co., Ltd.donated nearly RMB 3 million to China's fights against the pandemic and the floods in Henan Province. In the future, we will keep carrying out its corporate responsibilities in research fields related to people's livelihood. Sumitomo Pharma (Suzhou) Co., Ltd.will always stand behind China's medical industry. It will not only provide high-quality and accessible health solutions for Chinese patients but also actively introduce more new products and innovative means, thereby supporting Chinese patients and China's health sector, with a view of becoming a high-quality enterprise that makes continuous contributions to the development of China's medical industry.
